Adjusted vaccine effectiveness (VE) against pneumonia, acute exacerbation of cardiopulmonary disease, hospitalization, and mortality in patients with influenza-like Illness.</p
<p>*In these analyses, individuals vaccinated before the identified time duration considered unvacci...
The purpose of this study was to investigate whether individuals receiving influenza vaccines have a...
j Pneumonia and acute exacerbation of chronic illness are leading causes of influenza-related hospit...
To determine the clinical efficacy of combined vaccination with 23-valent pneumococcal vaccine (PV) ...
BackgroundInfluenza and pneumonia are leading causes of morbidity and mortality among the elderly. A...
BackgroundInfluenza and pneumonia are leading causes of morbidity and mortality among the elderly. A...
Influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza.</p
<p><b>Note.</b> Numbers adjacent to rates represent numerator counts of hospitalizations per period ...
<p><b>Note.</b> IVE = influenza vaccine effectiveness; CI = confidence interval; Hosp = hospitalizat...
<p>Estimates of PPSV23 and PCV13 vaccine effectiveness (VE) against invasive pneumococcal disease an...
<p>Positives admissions with influenza confirmed influenza by real time reverse transcription polyme...
<p>*Defined as diagnosis with one of following diseases: diabetes, chronic obstructive pulmonary dis...
BACKGROUND: The 2014-2015 influenza season was severe, with circulating influenza A (H3N2) viruses t...
Background: Influenza vaccination has been shown to reduce illness and all-cause mortality in vulner...
Updated May 18, 2023JYNNEOS vaccine is effective at reducing the risk of mpox, with two doses provid...
<p>*In these analyses, individuals vaccinated before the identified time duration considered unvacci...
The purpose of this study was to investigate whether individuals receiving influenza vaccines have a...
j Pneumonia and acute exacerbation of chronic illness are leading causes of influenza-related hospit...
To determine the clinical efficacy of combined vaccination with 23-valent pneumococcal vaccine (PV) ...
BackgroundInfluenza and pneumonia are leading causes of morbidity and mortality among the elderly. A...
BackgroundInfluenza and pneumonia are leading causes of morbidity and mortality among the elderly. A...
Influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza.</p
<p><b>Note.</b> Numbers adjacent to rates represent numerator counts of hospitalizations per period ...
<p><b>Note.</b> IVE = influenza vaccine effectiveness; CI = confidence interval; Hosp = hospitalizat...
<p>Estimates of PPSV23 and PCV13 vaccine effectiveness (VE) against invasive pneumococcal disease an...
<p>Positives admissions with influenza confirmed influenza by real time reverse transcription polyme...
<p>*Defined as diagnosis with one of following diseases: diabetes, chronic obstructive pulmonary dis...
BACKGROUND: The 2014-2015 influenza season was severe, with circulating influenza A (H3N2) viruses t...
Background: Influenza vaccination has been shown to reduce illness and all-cause mortality in vulner...
Updated May 18, 2023JYNNEOS vaccine is effective at reducing the risk of mpox, with two doses provid...
<p>*In these analyses, individuals vaccinated before the identified time duration considered unvacci...
The purpose of this study was to investigate whether individuals receiving influenza vaccines have a...
j Pneumonia and acute exacerbation of chronic illness are leading causes of influenza-related hospit...